Co-leads
Srividya Iyer, Ph.D.
Srividya Iyer is a Professor in the Department of Psychiatry at McGill University and a Researcher at the Douglas Hospital Research Centre. She is a licensed psychologist and an expert in youth mental health and early intervention for psychosis, in Canada and beyond. Iyer’s research focuses on ensuring that more young people globally have access to high-quality mental health care, and experience better outcomes, well-being, and social and economic participation.
Manuela Ferrari, Ph.D.
Manuela Ferrari is an Assistant Professor in the Department of Psychiatry at McGill University and a Researcher at the Douglas Hospital Research Centre. Dr. Ferrari applies participatory design to e-Mental Health interventions to enhance access to care, treatment, and client engagement with services. She has helped create different digital technologies and intervention for clinical use, including video games, apps, digital assessment and monitoring platform, and virtual reality training.
Team
Amal Abdel-Baki, MD
Amal Abdel-Baki is a psychiatrist at the Centre hospitalier de l’université de Montréal (CHUM), and Associate Professor in the Department of Psychiatry at the Université de Montréal. Dr. Abdel-Baki is a founder and President of the Association québécoise des programmes pour premiers épisodes psychotiques (AQPPEP), Quebec’s provincial association of 28 early psychosis programs. She founded and directs a large, well-established early psychosis clinic in Montreal.
Donald Addington, Ph.D.
Donald Addington is Professor Department of Psychiatry, University of Calgary Hotchkiss Brain Institute and Mathison Centre for Research & Education. His research has focused on quality and outcome of mental health services, particularly early intervention for psychosis.
Christopher Robert Bowie, Ph.D.
Christopher Robert Bowie is a Professor in the Department of Psychology, and a member of the Psychiatry Department and Centre for Neuroscience Studies, at Queen’s University in Kingston. He is the Head Consulting Psychologist at the Early Psychosis Intervention Program in Kingston and a Clinician Scientist at the Centre for Addiction and Mental Health in Toronto. His research interests focus on determining the causes and correlates, and developing treatments for, cognitive deficits in mental disorders such as schizophrenia and mood disorders.
Ridha Joober, MD
Ridha Joober is a psychiatrist and researcher at the Douglas Mental Health University Institute. He is the Director of the Prevention and Early Intervention Program for Psychosis (PEPP-Montreal), and is a Professor in the Departments of Psychiatry, Neurology and Human Genetics of the Faculty of Medicine of McGill University. Due to his engagement in both clinical and molecular investigations, Dr. Joober works to establish integrated research programs whose primary objective is to improve the care and wellbeing of patients and their families.
Marc-André Roy, MD
Marc-André Roy is a research psychiatrist and Full Professor of Psychiatry and Neuroscience at Université Laval. Since 1997 he has been working in early intervention at the Notre-Dame des Victoires Clinic of the Institut universitaire en santé mentale du Québec. His research focuses on this population, particularly on the development and evaluation of new treatments and on comorbidities. He received the Heinz Lehman 2020 award for his lifetime contribution to Quebec psychiatry.
Jai Shah, MD
Jai Shah is a psychiatrist and an Associate Professor of Psychiatry at McGill University, Dr. Shah is Associate Director of the Prevention and Early Intervention Program for Psychosis (PEPP) . He has been deeply involved in and committed to early intervention efforts, initially in psychosis and now expanding across youth mental health. He has engaged in an array of clinical research projects from neurobiology to health services and policy, with a particular focus on youth populations, the early phases of psychotic illness, clinical staging and stepped care models of mental illness.
Phil Tibbo, Ph.D.
Phil Tibbo is Professor and the Dr Paul Janssen Chair in Psychotic Disorders at Dalhousie University, Halifax. He is Clinical Director of Early Psychosis Intervention Nova Scotia (EPINS) and currently President of the Canadian Consortium for Early Intervention in Psychosis (CCEIP). Dr. Tibbo's research is primarily in the area of schizophrenia with his current foci of study including individuals at the early phase of, and at risk for, a psychotic illness.
